RESPONSE GENETICS INC
Healthcare · In Vitro & In Vivo Diagnostic Substances · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY14 | FY13 | FY12 | FY11 | FY10 | |
|---|---|---|---|---|---|
| Revenue | $16.7M | $19.8M | $18.7M | $22.6M | $21.3M |
| Operating income | −$13.0M | −$7.9M | −$7.7M | −$5.7M | −$4.9M |
| Net income | −$13.7M | −$8.0M | −$7.8M | −$5.7M | −$4.7M |
| Total assets | $13.4M | $18.1M | $16.6M | $7.9M | $10.6M |
| Total liabilities | $14.6M | $6.8M | $5.4M | $6.1M | $6.0M |
| Equity | $2.5M | $5.8M | −$542,211 | −$6.1M | −$3.3M |
| EPS (diluted) | $-0.35 | $-0.24 | $-0.29 | — | — |
| Shares out. | 38.7M | 32.8M | 24.8M | 19.5M | 18.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2014- Operating margin
- −77.8%
- Net margin
- −81.9%
- Return on equity
- −548.0%
- Return on assets
- −101.9%
- Return on capital (ROCE)
- −154.9%
- Liabilities / assets
- 108.7%
- Debt / equity
- 5.85×
- Book value / share
- $0.06
- Revenue growth (YoY)
- −15.6%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2014- Altman Z″ (distress)
- -22.47distress
- Accruals / assets
- 4.5%clean
- Beneish M-Score
- -2.43normal
- Piotroski F-Score
- 1/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 5 warning● 1 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Apr 2, 2012
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2010
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2009
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Bridger Management, Llc10% owner | Nov 18, 2015 | D | 1.8M | $0.00 |
| Bridger Management, Llc10% owner | Nov 13, 2015 | D | 547,100 | $0.00 |
| Bridger Management, Llc10% owner | Nov 10, 2015 | D | 60,000 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Director / officer change · Other material eventOct 14, 2015
- Other material eventOct 5, 2015
- Delisting / listing-standard noticeAug 26, 2015
- Entered a material agreement · Bankruptcy or receivership · New financial obligationAug 11, 2015
- Delisting / listing-standard noticeJul 6, 2015
- Entered a material agreement · New financial obligationJul 1, 2015
- Results of operationsMay 14, 2015
- Entered a material agreement · New financial obligationApr 8, 2015
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AAMENDMENT NO. 5Feb 16, 2016
- SC 13G/AFeb 12, 2016
- 4FORM 4Nov 20, 2015
- SC 13G/ANov 20, 2015
- 4FORM 4Nov 17, 2015
- 4FORM 4Nov 12, 2015
- 8-KFORM 8-KOct 14, 2015
- 8-KFORM 8-KOct 5, 2015
- 25-NSEAug 27, 2015
- 8-KFORM 8-KAug 26, 2015
- 8-KFORM 8-KAug 11, 2015
- SC 13G/ARESPONSE GENETICS 13G/AJul 9, 2015
- 8-KCURRENT REPORTJul 6, 2015
- 8-KFORM 8-KJul 1, 2015
- 10-QFORM 10-QMay 15, 2015